Soft Tissue Repair Market Demand, Dynamic Innovation in Technology & Insights 2032

 The global Soft Tissue Repair Market is valued at US$ 6.61 Billion as of now and is expected to reach ~US$ 11.66 Billion by the year 2032 at a CAGR of 5.8% between 2022 and 2032.

Soft tissue repair refers to a procedure restoring injured or damaged tissue like ligaments, muscle, and various other tissues. The soft tissues could be damaged due to strain, tearing of ligament, or damage to the tendons. Biological materials like xenografts, allografts, synthetic mesh act as soft tissue repair products.

To learn more about this report @ https://www.futuremarketinsights.com/reports/soft-tissue-repair-market

With increasing awareness regarding soft tissue repair products, the soft tissue repair market is bound to grow on an exorbitant note going forward. Also, the fact that almost 409K injuries were revolving around exercise equipment in the year 2021 can’t be ignored. Timely repair of soft tissue could avoid amputations. In such cases, diabetic patients need to be vigilant on continuous basis. This could thus avoid the worst things like osteoarthritis, peripheral vascular disease, and diabetes-related gangrene. Future Market Insights has walked through these facts and findings with future prospects in its latest market study entitled ‘Soft Tissue Repair Market’.

Key Takeaways from Soft Tissue Repair Market

  • North America holds a significant market share. This could be credited to the US being subject to prevalence of common and chronic conditions like diabetes, sports injuries, and various others.
  • Europe stands second on the analogous grounds.
  • Coming to the Asia-Pacific, China leads from the front with rising demand for medical assistance; namely hip reconstruction, elbow reconstruction, and knee reconstruction. India is expected to follow suit. Also, the country is witnessing road traffic accidents at an alarming rate. The Indian Head Injury Foundation has asserted that almost 60% of the injuries caused due to road mishaps result in traumatic brain injuries. Also, ~65% of the adolescent athletes herein suffer from sports injuries. As such, there would be nothing to stop the soft tissue repair market from growing in the forecast period.

Competitive Landscape

  • Smith & Nephew, in January 2021, completed acquisition of the Extremity Orthopedics arm of Integra LifeSciences Holdings Corporation.
  • BD, in December 2021, did acquire Tissuemed, Ltd. with the objective of complementing the former’s product portfolio by addition of a widely applicable surgical sealant to its biosurgery products.
  • Zimmer Biomet, in January 2021, acquired Relign, so as to aid in filling a vital gap with respect to the business of sports medicines.
  • Becton, Dickinson and Company, in July 2021, announced that it had acquired Tepha, Inc., so that it could explore the arena of proprietary resorbable polymer technology.
  • Aroa Biosurgery, in April 2021, did announce that it had obtained clearance from the US FDA for its Myriad Morcells. This myriad matrix’s powdered format does help to heal complex wounds.
  • Smith and Nephew, in February 2019, tabled the Double ENDOBUTTON Fixation Device. It was waiting for clearance from the US FDA till then. The basic purpose of this device is that of treating anterior glenoid bone loss by following bone block procedure (autograft or allograft) or Latarjet.
  • Medtronic’s Dextile Anatomical Mesh, in December 2019, did receive approval from the US FDA. It comes across as a hernia repair mesh that makes provisions for a broad coverage of myopectineal orifice for minimizing risk pertaining to recurrence and maintaining shape post passage of trocar.

“The fact that exploding geriatric population is at a greater risk of injuries related to soft tissue is expected to keep the cash registers ringing for Tissue Regeneration market in the forecast period”, says an analyst from Future Market Insights.

Key Companies Profiled:

  • B. Braun Melsungen AG
  • Baxter
  • C. R. Bard, Inc.
  • Smith & Nephew
  • Johnson & Johnson Services Inc.
  • Stryker
  • Medtronic
  • Acera Surgical Inc.
  • Arthrex Inc.
  • Integra LifeSciences
  • ACELITY L.P. Inc.
  • AROA BIOSURGERY LIMITED
  • Becton, Dickinson, and Company
  • CONMED
  • Human Regenerative Technologies, LLC
  • BioCer Entwicklungs-GmbH
  • Betatech Medical

Key Market Segments Covered in Soft Tissue Repair Industry Research

By Product:

  • Synthetic
  • Allograft
  • Xenograft
  • Alloplast

By Application:

  • Breast Reconstruction
  • Hernia
  • Dermatology
  • Orthopaedics
    • Sports Medicine
    • Dural Repair
    • Others
  • Dental Problems
  • Vaginal Sling
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Services
  • Clinics

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more